{"title": "Chemopreventative celecoxib fails to prevent schwannoma formation or sensorineural hearing loss in genetically engineered murine model of neurofibromatosis type 2", "doi": "10.18632/oncotarget.22002", "pmid": "29416648", "pmc": "PMC5787503", "isbns": [], "altmetric_jid": "4f6fa8213cf058f61000bc6f", "issns": ["1949-2553"], "journal": "Oncotarget", "cohorts": {"doc": 1, "pub": 1}, "abstract": "Mutations in the tumor suppressor gene NF2 lead to Neurofibromatosis type 2 (NF2), a tumor predisposition syndrome characterized by the development of schwannomas, including bilateral vestibular schwannomas with complete penetrance. Recent work has implicated the importance of COX-2 in schwannoma growth. Using a genetically engineered murine model of NF2, we demonstrate that selective inhibition of COX-2 with celecoxib fails to prevent the spontaneous development of schwannomas or sensorineural hearing loss in vivo, despite elevated expression levels of COX-2 in Nf2-deficient tumor tissue. These results suggest that COX-2 is nonessential to schwannomagenesis and that the proposed tumor suppressive effects of NSAIDs on schwannomas may occur through COX-2 independent mechanisms.", "context": {"all": {"count": 12662942, "mean": 7.795380945692, "rank": 143243, "pct": 98, "higher_than": 12519197}, "journal": {"count": 11847, "mean": 3.7407112949519, "rank": 68, "pct": 99, "higher_than": 11779}, "similar_age_3m": {"count": 387156, "mean": 11.582792524957, "rank": 8110, "pct": 97, "higher_than": 379042}, "similar_age_journal_3m": {"count": 928, "mean": 3.2837238403452, "rank": 6, "pct": 99, "higher_than": 922}}, "authors": ["Benjamin M. Wahle", "Eric T. Hawley", "Yongzheng He", "Abbi E. Smith", "Jin Yuan", "Andi R. Masters", "David R. Jones", "Jeffrey R. Gehlhausen", "Su-Jung Park", "Simon J. Conway", "D. Wade Clapp", "Charles W. Yates"], "type": "article", "handles": [], "altmetric_id": 29547964, "schema": "1.5.4", "is_oa": false, "cited_by_posts_count": 16, "cited_by_msm_count": 13, "cited_by_tweeters_count": 2, "cited_by_accounts_count": 15, "last_updated": 1521281298, "score": 98.5, "history": {"1y": 0, "6m": 0, "3m": 0, "1m": 0, "1w": 0, "6d": 0, "5d": 0, "4d": 0, "3d": 0, "2d": 0, "1d": 0, "at": 98.5}, "url": "http://dx.doi.org/10.18632/oncotarget.22002", "added_on": 1511854160, "published_on": 1508803200, "subjects": ["neoplasms"], "readers": {"citeulike": "0", "mendeley": "10", "connotea": "0"}, "readers_count": 10, "images": {"small": "https://badges.altmetric.com/?size=64&score=99&types=mmmmmmmt", "medium": "https://badges.altmetric.com/?size=100&score=99&types=mmmmmmmt", "large": "https://badges.altmetric.com/?size=180&score=99&types=mmmmmmmt"}, "details_url": "http://www.altmetric.com/details.php?citation_id=29547964"}